The results of this series, the largest reported to date, confirm a link between NF-κB and prostate cancer outcome and extend prior reports by showing that nuclear NF-κB (the biologically active form) is the strongest independent prognostic factor of biochemical relapse in men that underwent prostatectomy as assessed by a comprehensive multivariate analysis. The gene discussed is NFKB1; the disease is prostate cancer.